Metastatic Medulloblastoma: 18F-FDG and 68Ga-DOTANOC PET/CT in Response Evaluation.
Journal
Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109
Informations de publication
Date de publication:
01 May 2021
01 May 2021
Historique:
pubmed:
15
12
2020
medline:
7
5
2021
entrez:
14
12
2020
Statut:
ppublish
Résumé
We describe the utility of molecular imaging with 18F-FDG and 68Ga-DOTANOC PET for treatment response assessment in a case of metastatic medulloblastoma. 18F-FDG and 68Ga-DOTANOC PET/CT revealed extensive metastases to bone and bone marrow. Patient subsequently had an excellent response to systemic chemotherapy which was evidenced by resolution of tracer-avid skeletal lesions on both FDG and DOTANOC PET/CT.
Identifiants
pubmed: 33315670
pii: 00003072-202105000-00028
doi: 10.1097/RLU.0000000000003435
doi:
Substances chimiques
68Ga-DOTANOC
0
Organometallic Compounds
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e262-e263Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: none declared.
Références
Ostrom QT, de Blank PM, Kruchko C, et al. Alex’s Lemonade Stand Foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol . 2015;16 suppl 10(suppl 10):x1–x36.
Franceschi E, Hofer S, Brandes AA, et al. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol . 2019;20:e715–e728.
Thompson EM, Hielscher T, Bouffet E, et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol . 2016;17:484–495.
Kondoff SI, Milev MD, Laleva LN, et al. A case of early extraneural medulloblastoma metastases in a young adult. Asian J Neurosurg . 2015;10:331–333.
Zukotynski K, Fahey F, Kocak M, et al. 18 F-FDG PET and MR imaging associations across a spectrum of pediatric brain tumors: a report from the pediatric brain tumor consortium. J Nucl Med . 2014;55:1473–1480.
Tripathi M, Jain N, Jaimini A, et al. Demonstration of diffuse leptomeningeal metastasis in a treated case of medulloblastoma with F-18 FDG PET/CT. Clin Nucl Med . 2009;34:530–532.
Cavalla P, Schiffer D. Neuroendocrine tumors in the brain. Ann Oncol . 2001;12(suppl 2):S131–S134.
Arunraj ST, Parida GK, Damle NA, et al. 68 Ga-DOTANOC PET/CT in medulloblastoma. Clin Nucl Med . 2018;43:e145–e146.
Gandola L, Massimino M, Cefalo G, et al. Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol Off J Am Soc Clin Oncol . 2009;27:566–571.
Warren KE, Vezina G, Poussaint TY, et al. Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-oncology Committee. Neuro Oncol . 2018;20:13–23.